SIG
DNA icon

Senator Investment Group’s Ginkgo Bioworks DNA Stock Holding History

Senator Investment Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-278,381
Closed -$22.9M – 53
2022
Q2 		$22.9M Sell
278,381
-872,003
-76% -$106M 1.64% 21
2022
Q1 		$176M Sell
1,150,384
-764,496
-40% -$149M 5.46% 3
2021
Q4 		$565M Sell
1,914,880
-52,702
-3% -$25M 10.92% 1
2021
Q3 		$912M Buy
+1,967,582
New +$958M 15.61% 1

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Senator Investment Group's DNA Position: Q3 2022 in Review

Senator Investment Group sold out of Ginkgo Bioworks (DNA) in Q3 2022, closing a stake of 278,381 shares — an estimated $22.9M sold.

Senator Investment Group first reported a position in DNA in Q3 2021 and held it in 4 quarters. The position peaked at $912M in Q3 2021. 278 funds tracked by Wall St. Rank hold DNA as of Q3 2022.

  • Senator Investment Group reported no remaining Ginkgo Bioworks position as of Q3 2022 after selling out during the quarter.
  • Senator Investment Group sold 278,381 Ginkgo Bioworks shares in Q3 2022, an estimated $22.9M.
  • Senator Investment Group first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 4 quarters.
  • Senator Investment Group's Ginkgo Bioworks position peaked at $912M in Q3 2021.
  • 278 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2022.

Based on Senator Investment Group's 13F filing for Q3 2022, filed 10 Nov 2022.